Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The molecular adaptor
Fe65
is one of the cytosolic ligands of the Alzheimer's beta-amyloid precursor protein (APP), and this complex is believed to play important roles in mammalian cells. Upon cleavage of APP by specific processing activities, the complex between
Fe65
and the APP intracellular domain (AICD) translocates to the nucleus. Experimental evidence suggests that the
Fe65
-AICD complex regulates gene transcription. In Caenorhabditis elegans the orthologue of the
Fe65
gene, feh-1, regulates pharyngeal activity. In fact, the rate of pharyngeal contraction is increased following transient or stable suppression of the feh-1 gene expression. Here we show that the increased contraction rate of the pharynx in feh-1 mutant worms is associated to decreased
acetylcholinesterase
activity. The decreased activity is accompanied by reduced expression of ace-1 and ace-2 transcripts, coding for the two major
acetylcholinesterase
activities in the nematode. These results indicate a target of the regulatory mechanisms based on the
Fe65
-APP complex that could be relevant for the pathogenesis of Alzheimer's disease.
...
PMID:Mutation of the feh-1 gene, the Caenorhabditis elegans orthologue of mammalian Fe65, decreases the expression of two acetylcholinesterase genes. 1535 15